PATENT CLAIM ANALYSIS

Application Number: 15882065
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "017900"]

Abstract:
The disclosure provides for peptides from syndecan 1 and methods of use therefor. These peptides can inhibit VLA-4 interaction with VEGFR2, thereby preventing tumor cell growth and tissue invasion.

Claim (Index 2):
The method of  claim 1 , wherein the peptide segment is 12, 13, 14, 15, 16, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 40, 45, 49, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 amino acid residues in length.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.10345
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15043951', '15680423', '13936854', '14688927', '15296218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7841083975371254
- 35 USC 102 Novelty (BERT): 0.7008586514916928
- Combined Prediction Score: 0.7757834229325821
- Mean Citation Score: 475.912768
- Max Citation Score: 715.2966299999997
- Similarity Product: 709.4857351000819

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test